Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by Tumbleweed67on Nov 10, 2011 3:26pm
160 Views
Post# 19227494

RE: RE: RE: RE: RE: RE: RE: RE: RE: RE: RE: Today'

RE: RE: RE: RE: RE: RE: RE: RE: RE: RE: RE: Today'Proof?
I ask you again...using your theory, WHAT WAS BYPASSED?
Your theory doesn't make sense.
A more likely scenario is there was an iceberg order to BUY shares which got bypassed by the Scotia sell.
And don't be surprised if it's not related to your big bid this a.m.
Probably choked at missing those 200k shares yesterday and changed strategy.

TW
Bullboard Posts